title: The Mysterious Ways of ErbB2/HER2 Trafficking.
abstract: The EGFR- or ErbB-family of receptor tyrosine kinases consists of EGFR/ErbB1, ErbB2/HER2, ErbB3/HER3 and ErbB4/HER4. Receptor activation and downstream signaling are generally initiated upon ligand-induced receptor homo- or heterodimerization at the plasma membrane, and endocytosis and intracellular membrane transport are crucial for regulation of the signaling outcome. Among the receptors, ErbB2 is special in several ways. Unlike the others, ErbB2 has no known ligand, but is still the favored dimerization partner. Furthermore, while the other receptors are down-regulated either constitutively or upon ligand-binding, ErbB2 is resistant to down-regulation, and also inhibits down-regulation of its partner upon heterodimerization. The reason(s) why ErbB2 is resistant to down-regulation are the subject of debate. Contrary to other ErbB-proteins, mature ErbB2 needs Hsp90 as chaperone. Several data suggest that Hsp90 is an important regulator of factors like ErbB2 stability, dimerization and/or signaling. Hsp90 inhibitors induce degradation of ErbB2, but whether Hsp90 directly makes ErbB2 endocytosis resistant is unclear. Exposure to anti-ErbB2 antibodies can also induce down-regulation of ErbB2. Down-regulation induced by Hsp90 inhibitors or antibodies does at least partly involve internalization and endosomal sorting to lysosomes for degradation, but also retrograde trafficking to the nucleus has been reported. In this review, we will discuss different molecular mechanisms suggested to be important for making ErbB2 resistant to down-regulation, and review how membrane trafficking is involved when down-regulation and/or relocalization of ErbB2 is induced.
authors.affiliation: Department of Pathology, Oslo University Hospital, Rikshospitalet, Post Box 4950 Nydalen, 0424 Oslo, Norway. vibeke.bertelsen@rr-research.no.
authors.forename: Vibeke
authors.initials: V
authors.lastname: Bertelsen
authors.affiliation: Department of Pathology, Oslo University Hospital, Rikshospitalet, Post Box 4950 Nydalen, 0424 Oslo, Norway. espsta@rr-research.no.
authors.forename: Espen
authors.initials: E
authors.lastname: Stang
references.citation: J Cell Sci. 2006 Jan 1;119(Pt 1):85-95
references.pmid: 16352662
references.citation: Arch Biochem Biophys. 2010 Jul;499(1-2):49-55
references.pmid: 20460098
references.citation: Mol Carcinog. 2011 Nov;50(11):901-12
references.pmid: 21438025
references.citation: Histochem Cell Biol. 2013 Sep;140(3):307-15
references.pmid: 23851467
references.citation: Mol Cell Biol. 2007 Jan;27(1):220-8
references.pmid: 17030621
references.citation: Nat Rev Cancer. 2008 Jul;8(7):491-5
references.pmid: 18511936
references.citation: Cancer Res. 2003 Mar 1;63(5):1130-7
references.pmid: 12615732
references.citation: Cancer Cell. 2004 Sep;6(3):251-61
references.pmid: 15380516
references.citation: Cancer Res. 2001 Jun 15;61(12):4892-900
references.pmid: 11406568
references.citation: Curr Opin Genet Dev. 2005 Feb;15(1):55-61
references.pmid: 15661534
references.citation: Proc Natl Acad Sci U S A. 2014 May 6;111(18):6834-9
references.pmid: 24760825
references.citation: Oncogene. 2013 Jul 18;32(29):3443-51
references.pmid: 22869152
references.citation: Cell Biosci. 2012 Apr 20;2(1):13
references.pmid: 22520625
references.citation: Mol Cancer Ther. 2011 Aug;10(8):1367-74
references.pmid: 21673090
references.citation: Int J Cancer. 2005 Sep 1;116(3):359-67
references.pmid: 15800944
references.citation: Sci STKE. 2007 May 08;2007(385):pe22
references.pmid: 17488976
references.citation: Oncogene. 2009 Feb 12;28(6):803-14
references.pmid: 19060928
references.citation: J Biol Chem. 2001 Sep 7;276(36):33675-80
references.pmid: 11402024
references.citation: Mol Cancer Res. 2008 Mar;6(3):491-500
references.pmid: 18337455
references.citation: Cell. 2012 Mar 16;148(6):1081-4
references.pmid: 22424219
references.citation: Exp Cell Res. 2009 Feb 15;315(4):683-96
references.pmid: 19278030
references.citation: Oncogene. 2014 Jun 26;33(26):3422-31
references.pmid: 23912457
references.citation: EMBO J. 2006 Jul 12;25(13):3234-44
references.pmid: 16794579
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3294-9
references.pmid: 19218427
references.citation: Cold Spring Harb Perspect Biol. 2013 Nov 01;5(11):a016790
references.pmid: 24186068
references.citation: Oncogene. 2010 Jan 21;29(3):325-34
references.pmid: 19855434
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1915-20
references.pmid: 15684082
references.citation: Drug Discov Today. 2011 Sep;16(17-18):810-6
references.pmid: 21704182
references.citation: Nat Struct Mol Biol. 2005 Feb;12(2):120-6
references.pmid: 15643424
references.citation: Cell. 2006 Jun 16;125(6):1137-49
references.pmid: 16777603
references.citation: Biochim Biophys Acta. 2012 Mar;1823(3):730-41
references.pmid: 21982864
references.citation: PLoS One. 2009 Jun 16;4(6):e5933
references.pmid: 19529774
references.citation: J Cell Sci. 2009 Oct 1;122(Pt 19):3433-9
references.pmid: 19759283
references.citation: J Cell Sci. 2008 Oct 1;121(Pt 19):3155-66
references.pmid: 18765569
references.citation: EMBO Rep. 2004 Dec;5(12):1165-70
references.pmid: 15568014
references.citation: Mol Biol Cell. 2007 Sep;18(9):3656-66
references.pmid: 17626164
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12847-52
references.pmid: 12239347
references.citation: Traffic. 2012 Aug;13(8):1106-12
references.pmid: 22531034
references.citation: J Cell Biochem. 2006 Aug 15;98(6):1570-83
references.pmid: 16552725
references.citation: Mol Cell. 2003 Sep;12(3):541-52
references.pmid: 14527402
references.citation: J Cell Sci. 2012 Jan 15;125(Pt 2):265-75
references.pmid: 22357968
references.citation: J Cell Sci. 2002 Nov 15;115(Pt 22):4251-62
references.pmid: 12376557
references.citation: Cancer Treat Rev. 2012 Apr;38(2):133-42
references.pmid: 21549508
references.citation: Cell Signal. 2012 Nov;24(11):1981-8
references.pmid: 22800866
references.citation: Cancer Biol Ther. 2006 Jun;5(6):657-64
references.pmid: 16627989
references.citation: J Biol Chem. 2008 Jan 25;283(4):2031-41
references.pmid: 18056992
references.citation: Cancer Res. 2000 Jul 1;60(13):3384-8
references.pmid: 10910043
references.citation: Cancer Res. 2001 Jun 15;61(12):4744-9
references.pmid: 11406546
references.citation: Proteomics. 2009 May;9(10):2820-35
references.pmid: 19415654
references.citation: Exp Cell Res. 2012 Dec 10;318(20):2578-91
references.pmid: 22975728
references.citation: Mol Cell Biol. 2006 Jan;26(2):389-401
references.pmid: 16382132
references.citation: Pharmaceuticals (Basel). 2012 Jun 28;5(7):674-89
references.pmid: 24281706
references.citation: Cancer Cell. 2009 May 5;15(5):429-40
references.pmid: 19411071
references.citation: Biochem Biophys Res Commun. 2010 Sep 3;399(4):498-504
references.pmid: 20674546
references.citation: PLoS One. 2013;8(3):e58148
references.pmid: 23472148
references.citation: Cancer Res. 1991 Oct 1;51(19):5361-9
references.pmid: 1680547
references.citation: Mol Biol Cell. 2007 Mar;18(3):1064-72
references.pmid: 17215517
references.citation: J Cell Physiol. 2011 Jan;226(1):52-7
references.pmid: 20658522
references.citation: Cancer Cell. 2004 Apr;5(4):317-28
references.pmid: 15093539
references.citation: J Biol Chem. 2010 Dec 3;285(49):38720-9
references.pmid: 20937808
references.citation: Cancer Biol Ther. 2011 Jan 15;11(2):263-76
references.pmid: 21088503
references.citation: Mol Cell Proteomics. 2014 Jan;13(1):145-56
references.pmid: 24142993
references.citation: PLoS One. 2012;7(12):e51817
references.pmid: 23284778
references.citation: Exp Cell Res. 2003 Mar 10;284(1):54-65
references.pmid: 12648465
references.citation: Cancer Res. 2003 Jan 1;63(1):39-43
references.pmid: 12517775
references.citation: EMBO J. 2013 Jul 31;32(15):2140-57
references.pmid: 23799367
references.citation: Mol Biol Cell. 1999 May;10(5):1621-36
references.pmid: 10233167
references.citation: Cold Spring Harb Perspect Biol. 2013 Oct 01;5(10):a008979
references.pmid: 24086039
references.citation: Mol Cell Biol. 2010 Dec;30(23):5456-72
references.pmid: 20876300
references.citation: J Biol Chem. 2001 Feb 2;276(5):3702-8
references.pmid: 11071886
references.citation: Mol Cell Biol. 1989 Mar;9(3):1165-72
references.pmid: 2566907
references.citation: Carcinogenesis. 2012 May;33(5):1031-9
references.pmid: 22436610
references.citation: Mol Biol Cell. 2004 Apr;15(4):1557-67
references.pmid: 14742716
references.citation: Mol Cell Biol. 2005 Dec;25(24):11005-18
references.pmid: 16314522
references.citation: Cancer Cell. 2002 Aug;2(2):127-37
references.pmid: 12204533
references.citation: Mol Biol Cell. 2013 Jan;24(2):129-44
references.pmid: 23154999
references.citation: Cancer Biol Ther. 2007 Dec;6(12):1960-6
references.pmid: 18075296
references.citation: J Biol Chem. 2000 Aug 25;275(34):26625-31
references.pmid: 10862618
references.citation: J Cell Biol. 2010 May 31;189(5):871-83
references.pmid: 20513767
references.citation: Int Rev Cell Mol Biol. 2013;303:203-35
references.pmid: 23445811
references.citation: Mol Biol Cell. 2005 Jun;16(6):2704-18
references.pmid: 15772153
references.citation: FEBS J. 2013 Mar;280(6):1381-96
references.pmid: 23356585
references.citation: Oncogene. 2012 Jun 14;31(24):2953-67
references.pmid: 21986942
references.citation: Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20330-5
references.pmid: 19933325
references.citation: Cancer Res. 2009 Aug 1;69(15):6179-83
references.pmid: 19602593
references.citation: Exp Cell Res. 2013 Feb 1;319(3):32-45
references.pmid: 23127513
references.citation: Cancer Res. 2004 Apr 1;64(7):2343-6
references.pmid: 15059883
references.citation: Cancer Sci. 2007 Oct;98(10):1536-9
references.pmid: 17645779
references.citation: Cell Cycle. 2009 Feb 1;8(3):362-72
references.pmid: 19177013
references.citation: Cell Cycle. 2008 Jun 1;7(11):1564-8
references.pmid: 18469526
references.citation: Oncogene. 2015 Jan 2;34(1):15-26
references.pmid: 24292678
references.citation: Nat Cell Biol. 2001 Sep;3(9):802-8
references.pmid: 11533659
references.citation: J Biol Chem. 2012 May 11;287(20):16869-79
references.pmid: 22451678
references.citation: J Biol Chem. 2007 Apr 6;282(14):10432-40
references.pmid: 17283074
references.citation: J Biol Chem. 2003 Apr 18;278(16):13829-37
references.pmid: 12574167
references.citation: Mol Biol Cell. 2004 Dec;15(12):5268-82
references.pmid: 15385631
references.citation: Mol Cell Biol. 2011 Jul;31(14):3009-18
references.pmid: 21576364
references.citation: Nat Rev Cancer. 2010 Aug;10(8):537-49
references.pmid: 20651736
references.citation: Semin Oncol. 2001 Oct;28(5 Suppl 16):4-11
references.pmid: 11706390
references.citation: PLoS One. 2012;7(8):e42722
references.pmid: 22912728
references.citation: Mol Cancer Ther. 2009 Jul;8(7):1885-92
references.pmid: 19584234
references.citation: Cell Signal. 2011 Feb;23(2):458-67
references.pmid: 21044682
references.citation: Oncogene. 2000 Dec 11;19(53):6102-14
references.pmid: 11156523
references.citation: Oncogene. 1993 Nov;8(11):3021-8
references.pmid: 8105439
references.citation: Nat Rev Mol Cell Biol. 2010 Jul;11(7):515-28
references.pmid: 20531426
references.citation: J Cell Biol. 2002 Mar 4;156(5):843-54
references.pmid: 11864992
references.citation: Cell Signal. 2008 Apr;20(4):779-86
references.pmid: 18255265
references.citation: Traffic. 2009 Aug;10(8):1115-27
references.pmid: 19531065
references.citation: Cancer Res. 2010 May 1;70(9):3709-17
references.pmid: 20406983
references.citation: Histochem Cell Biol. 2008 May;129(5):563-78
references.pmid: 18288481
references.citation: Cancer Res. 2011 Mar 1;71(5):1871-82
references.pmid: 21324925
references.citation: Mol Cell. 2003 Feb;11(2):495-505
references.pmid: 12620236
references.citation: J Biol Chem. 1996 Mar 1;271(9):5251-7
references.pmid: 8617810
references.citation: Cell Cycle. 2014;13(5):681-2
references.pmid: 24526125
references.citation: Carcinogenesis. 2013 Sep;34(9):2031-8
references.pmid: 23698633
references.citation: Mol Biol Cell. 2005 Dec;16(12):5832-42
references.pmid: 16207817
references.citation: Biochem Biophys Res Commun. 2011 Aug 26;412(2):341-6
references.pmid: 21821003
references.citation: PLoS One. 2013 Jul 02;8(7):e68394
references.pmid: 23844194